Rockstone’s iQ Spaces to build Berlin’s gene therapy centre

Rockstone Capital Partners life science platform subsidiary iQ spaces is to develop the €180m Berlin Center for Gene and Cell Therapies, a project initiated by Bayer AG and the Charité – Universitätsmedizin Berlin.

You have reached premium content

Our readers look to Real Asset Insight to stay informed about the issues that matter in the real asset markets. Log in, start a free trial or subscribe below.

45 Day Free Trial – Real Asset INSIGHT & IMPACT Premium Membership
Start your trial today
0.00
30 days full access

Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.

45 DAY TRIAL MEMBERSHIP

Be part of the leading real asset community!

Get your free trial now
Real Asset INSIGHT Premium
Taking you beyond the headlines
495.00
12 month Subscription

SUBSCRIBE NOW

Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.

Be part of the leading real asset community and subscribe now! 

Subscribe now
Author: